Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shikoku Chemicals Corporation (4099.T)
Marugame, JP
Shikoku Chemicals Corporation, established in Marugame, Japan, in 1947, operates globally in the research, development, production, and sale of a wide array of chemical products and construction materials. Its chemical offerings are categorized into: Inorganic chemicals, such as insoluble sulfur, carbon disulfide, and sodium sulfate and carbonate. Organic chemicals, which include chlorinated isocyanurates, various automatic chlorine feeding systems (standard and differential pressure), bacterial enzymes, and urinary calculus removers. Fine chemicals, comprising imidazole and adduct-type latent curing agents for epoxy resins; cross-linkers for thermosetting and UV-curable resins; benzoxazine; adhesion improvers; low volatile cross-linking agents; THEIC; imidazole and other heterocycles; organic solderability preservatives; chemical adhesion processes; and microetching solutions. In the housing materials sector, the company provides interior, exterior, and paving finishes, along with outdoor products like gates, fences, carports, decks, and terraces. Beyond these core businesses, Shikoku Chemicals engages in a diverse range of activities, including: The design, manufacturing, development, and installation of shutters and other retail outlet fixtures, supported by technical services. Development, sale, and system management of computer software. Operation of Mosburger hamburger restaurants. Sales of giftware and daily use products. Comprehensive water treatment services, from the design, installation, and maintenance of sewage and septic tank systems, to drainage pipe construction, and the inspection and cleaning of water storage tanks. Collection and transportation of general and industrial waste materials. Provision of information services. Acting as an agency for damage and life insurance. Packaging and transportation services. Housing renovation and solar photovoltaic power generation. Environmental measurement authentication and quality testing for drinking water.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.87% | +7.25% | +19.09% | +20.59% | +102.03% | +111.67% | +208.56% | +302.09% | +383.65% | +567.82% | +1,430.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+1.7% Q1'26: +18.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+0.9% Q1'26: +63.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+15.4% ★ Q1'26: +21.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.5% ★ Q1'26: +14.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-4.9% ★ Q1'26: -3.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.69× ★ Q1'26: 1.21× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
47.04B
est: 48.20B (-2.4%)
|
49.15B
est: 51.05B (-3.7%)
|
50.25B
est: 49.23B (+2.1%)
|
49.47B
est: 50.50B (-2.0%)
|
50.79B
est: 52.50B (-3.3%)
|
52.81B
est: 51.30B (+2.9%)
|
51.56B
est: 51.30B (+0.5%)
|
49.59B
est: 49.00B (+1.2%)
|
54.14B
est: 53.50B (+1.2%)
|
61.47B
est: 47.00B (+30.8%)
|
63.12B
est: 62.50B (+1.0%)
|
69.49B
est: 69.50B (0.0%)
|
70.71B
est: 70.75B (-0.1%)
|
78.50B
76.65B – 80.35B
+11.0% YoY
|
84.50B
80.58B – 88.42B
+7.6% YoY
|
91.50B
89.35B – 93.65B
+8.3% YoY
|
| EBITDA |
7.89B
est: 9.63B (-18.1%)
|
8.44B
est: 10.20B (-17.3%)
|
9.15B
est: 9.84B (-7.0%)
|
9.93B
est: 10.09B (-1.6%)
|
11.49B
est: 10.49B (+9.5%)
|
10.11B
est: 10.25B (-1.4%)
|
10.25B
est: 10.25B (+0.0%)
|
10.11B
est: 9.79B (+3.3%)
|
11.40B
est: 10.69B (+6.7%)
|
12.67B
est: 9.39B (+34.9%)
|
14.75B
est: 12.49B (+18.1%)
|
15.69B
est: 14.38B (+9.1%)
|
14.41B
est: 14.64B (-1.6%)
|
16.24B
15.86B – 16.62B
+11.0% YoY
|
17.48B
16.67B – 18.30B
+7.6% YoY
|
18.93B
18.49B – 19.38B
+8.3% YoY
|
| EBIT |
6.03B
est: 7.25B (-16.9%)
|
6.69B
est: 7.68B (-12.8%)
|
7.40B
est: 7.40B (0.0%)
|
8.29B
est: 7.60B (+9.1%)
|
9.17B
est: 7.90B (+16.2%)
|
7.83B
est: 7.72B (+1.5%)
|
8.07B
est: 7.72B (+4.5%)
|
8.28B
est: 7.37B (+12.3%)
|
8.40B
est: 8.05B (+4.4%)
|
9.85B
est: 7.07B (+39.3%)
|
11.40B
est: 9.40B (+21.3%)
|
12.63B
est: 11.35B (+11.3%)
|
10.87B
est: 11.55B (-5.9%)
|
12.82B
12.51B – 13.12B
+11.0% YoY
|
13.80B
13.16B – 14.44B
+7.6% YoY
|
14.94B
14.59B – 15.29B
+8.3% YoY
|
| Net Income |
3.92B
est: 3.29B (+19.2%)
|
4.36B
est: 4.21B (+3.6%)
|
4.85B
est: 3.79B (+28.0%)
|
5.84B
est: 5.03B (+16.1%)
|
6.61B
est: 4.75B (+39.2%)
|
5.40B
est: 4.48B (+20.5%)
|
5.61B
est: 4.48B (+25.2%)
|
5.76B
est: 4.43B (+29.9%)
|
6.88B
est: 5.65B (+21.7%)
|
7.08B
est: 4.02B (+76.3%)
|
7.85B
est: 6.54B (+20.1%)
|
8.81B
est: 7.80B (+13.0%)
|
8.46B
est: 8.20B (+3.2%)
|
10.66B
10.33B – 10.98B
+30.0% YoY
|
12.29B
11.40B – 13.18B
+15.3% YoY
|
14.44B
14.00B – 14.88B
+17.5% YoY
|
| SGA |
10.28B
est: 8.78B (+17.1%)
|
10.37B
est: 9.30B (+11.5%)
|
11.01B
est: 8.96B (+22.8%)
|
11.14B
est: 9.20B (+21.1%)
|
11.40B
est: 9.56B (+19.2%)
|
11.79B
est: 9.34B (+26.2%)
|
11.90B
est: 9.34B (+27.4%)
|
11.48B
est: 8.92B (+28.6%)
|
6.44B
est: 9.74B (-33.9%)
|
14.78B
est: 8.56B (+72.7%)
|
13.87B
est: 11.38B (+21.8%)
|
16.12B
est: 14.75B (+9.3%)
|
17.67B
est: 15.01B (+17.7%)
|
16.66B
16.26B – 17.05B
+11.0% YoY
|
17.93B
17.10B – 18.76B
+7.6% YoY
|
19.42B
18.96B – 19.87B
+8.3% YoY
|
| EPS |
67.14
est: 71.50 (-6.1%)
|
74.62
est: 91.40 (-18.4%)
|
83.07
est: 82.37 (+0.9%)
|
99.90
est: 109.20 (-8.5%)
|
113.14
est: 103.10 (+9.7%)
|
92.38
est: 97.30 (-5.1%)
|
96.90
est: 97.30 (-0.4%)
|
103.26
est: 96.30 (+7.2%)
|
125.52
est: 122.70 (+2.3%)
|
132.19
est: 87.20 (+51.6%)
|
152.11
est: 142.05 (+7.1%)
|
191.37
est: 178.10 (+7.5%)
|
193.11
est: 191.40 (+0.9%)
|
243.30
235.85 – 250.75
+27.1% YoY
|
280.60
260.34 – 300.86
+15.3% YoY
|
329.70
319.61 – 339.79
+17.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares International Small-Cap Equity Factor ETF ISCF | 0.17% | 1.12M | 0.24% |
| 2 | State Street SPDR S&P International Small Cap ETF GWX | 0.12% | 1.01M | 0.40% |
| 3 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.07% | 401.2K | 0.58% |
| 4 | iShares MSCI Japan Small-Cap ETF SCJ | 0.07% | 180.0K | 0.50% |
| 5 | Schwab International Small-Cap Equity ETF SCHC | 0.04% | 2.34M | 0.06% |
| 6 | Avantis International Small Cap Value ETF AVDV | 0.03% | 5.89M | 0.36% |
| 7 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.03% | 4.07M | 0.06% |
| 8 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.03% | 60.8K | 0.83% |
| 9 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.03% | 3.66M | 0.40% |
| 10 | iShares Core MSCI Japan IMI UCITS ETF IJPA.L | 0.02% | 1.47M | 0.12% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Makoto Hamazaki | Senior Managing Executive & Executive Director | — | male |
| Mitsunori Watanabe | President, Chief Executive Officer, Group Compliance Officer & Representative Director | — | male |
| Yoshiaki Ando | Director & Head of Corporate Management | — | male |
| Yoshinori Manabe | MD & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4099.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
